STAAR Surgical
STAA
194 hedge funds and large institutions have $1.83B invested in STAAR Surgical in 2018 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 68 increasing their positions, 49 reducing their positions, and 12 closing their positions.
358% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 12
156% more call options, than puts
Call options by funds: $22.2M | Put options by funds: $8.67M
68% more capital invested
Capital invested by funds: $1.08B → $1.83B (+$741M)
39% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 49
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
28% more funds holding
Funds holding: 151 → 194 (+43)
2.53% more ownership
Funds ownership: 84.02% → 86.56% (+2.5%)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$42.7M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$16M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$14M |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.4M |
| 5 |
Millennium Management
New York
|
+$12.1M |
Top Sellers
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$82.7M |
| 2 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$11.3M |
| 3 |
D.E. Shaw & Co
New York
|
-$8.38M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$6.32M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$3.99M |
STAA Hedge Fund Activity: Q3 2018 in Review
194 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q3 2018, worth a combined $1.83B — up 68% from $1.08B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new STAA positions and 12 closed out — a net gain of 43 holders — while 68 added to existing stakes and 49 trimmed.
The largest buyer was Vanguard Group, adding an estimated $42.7M. The largest seller was Putnam Investments, cutting an estimated $82.7M.
- 194 institutional investors held STAAR Surgical (STAA) as of Q3 2018, up from 151 in Q2 2018.
- Funds reported $1.83B of STAAR Surgical stock for Q3 2018, up 68% quarter-over-quarter.
- 55 funds opened new STAAR Surgical positions in Q3 2018 and 12 closed out, a net change of +43 holders.
- The largest STAAR Surgical buyer in Q3 2018 was Vanguard Group, an estimated $42.7M added.
- The largest STAAR Surgical seller in Q3 2018 was Putnam Investments, an estimated $82.7M sold.
Based on aggregated 13F filings for Q3 2018.